ReviewExpert opinion on therapeutic targets2011

Targeting ligand-operated chaperone sigma-1 receptors in the treatment of neuropsychiatric disorders.

Teruo Hayashi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.